Inventor · disambiguated record
Bruce Reidenberg
Also filed as: REIDENBERG BRUCE · REIDENBERG BRUCE E
12 granted patents·24 pending applications·71 citations·filing 1998–2024
88Inventor score
Top patents by PatentIndex Score
36 records- 0186US8790689B2Tamper resistant transdermal dosage formHOWARD STEPHEN A·Filed 2005·Granted Jul 29, 2014·8 cites·17 claims
- 0281US7270830B2Transdermal buprenorphine dosage regimen for analgesiaPURDUE PHARMA LP·Filed 2003·Granted Sep 18, 2007·22 cites·47 claims
- 0379US2025144111A1Taurolidine treatment for myc-expressing tumors in mammalian bodiesCORMEDIX INC·Filed 2024·Application pending·0 cites
- 0478US7413748B2Transdermal buprenorphine to treat pain in sickle cell crisisPURDUE PHARMA LP·Filed 2003·Granted Aug 19, 2008·11 cites·60 claims
- 0575US12053478B2Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodiesCORMEDIX INC·Filed 2021·Granted Aug 6, 2024·0 cites·10 claims
- 0674US7125884B2N-but-3-enyl norbuprenorphine and its use as analgesicEURO CELTIQUE SA·Filed 2002·Granted Oct 24, 2006·14 cites·20 claims
- 0774US2025099480A1Methods and pharmaceutical compositions for treating candida auris in bloodCORMEDIX INC·Filed 2024·Application pending·0 cites
- 0870US8778382B2Tamper resistant transdermal dosage formHOWARD STEPHEN A·Filed 2004·Granted Jul 15, 2014·7 cites·20 claims
- 0969US11541061B2Neuroblastoma treatment with taurolidine hydrolysis productsCORMEDIX INC·Filed 2019·Granted Jan 3, 2023·0 cites·3 claims
- 1069US2023390300A1Neuroblastoma treatment with taurolidine hydrolysis productsCORMEDIX INC·Filed 2022·Application pending·0 cites
- 1168US2019381060A1Taurolidine treatment for myc-expressing tumors in mammalian bodiesCORMEDIX INC·Filed 2019·Application pending·0 cites
- 1267US12016865B2Methods and pharmaceutical compositions for treating candida auris in bloodCORMEDIX INC·Filed 2018·Granted Jun 25, 2024·0 cites·14 claims
- 1366US2022347184A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2022·Application pending·0 cites
- 1465US5883097ASoluble azole antifungal saltSCHERING CORP·Filed 1998·Granted Mar 16, 1999·9 cites·18 claims
- 1565US2022323450A1Methods and compositions for treating neuroblastoma in a juvenile mammalian bodyCORMEDIX INC·Filed 2021·Application pending·0 cites
- 1662US2019381058A1Methods and compositions for treating neuroblastoma in a juvenile mammalian bodyCORMEDIX INC·Filed 2019·Application pending·0 cites
- 1758US2014199383A1Abuse resistant opioid containing transdermal systemsPURDUE PHARMA LP·Filed 2014·Application pending·0 cites
- 1858US2021093641A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2020·Application pending·0 cites
- 1957US2021220349A1Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinsons diseaseVERSI GROUP LLC·Filed 2021·Application pending·0 cites
- 2056US2018117058A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2017·Application pending·0 cites
- 2155US2008020028A1Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agentEURO CELTIQUE SA·Filed 2007·Application pending·0 cites
- 2253US2014221413A1Preoperative treatment of post operative painPURDUE PHARMA LP·Filed 2014·Application pending·0 cites
- 2352US2008026042A1Preoperative Treatment of Post Operative PainEURO CELTIQUE SA·Filed 2004·Application pending·0 cites
- 2450US2004241218A1Abuse resistant opioid containing transdermal systemsFiled 2002·Application pending·0 cites
- 2548US10973815B2Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons diseaseVERSI GROUP LLC·Filed 2017·Granted Apr 13, 2021·0 cites·5 claims
- 2646US2011002975A1Preoperative treatment of post operative painPURDUE PHARMA LP·Filed 2010·Application pending·0 cites
- 2746US2018207103A1Use of an injectable antimicrobial composition for the prevention and/or treatment of osteoarthritisCORMEDIX INC·Filed 2018·Application pending·0 cites
- 2845US2008233178A1Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist MicrospheresEURO CELTIQUE SA·Filed 2005·Application pending·0 cites
- 2944US2017100407A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2016·Application pending·0 cites
- 3042US10478640B2Field sterilizer and vascular connector kitCORMEDIX INC·Filed 2017·Granted Nov 19, 2019·0 cites·3 claims
- 3142US2017157114A1Abuse resistant opioid transdermal delivery device containing opioid antagonist microspheresPURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 3239US2004126323A1Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agentFiled 2003·Application pending·0 cites
- 3338US2005192308A1N-but-E-enyl norbuprenorphine and methods of useFiled 2005·Application pending·0 cites
- 3436US8637073B2Treatment of dependence withdrawalREIDENBERG BRUCE E·Filed 2004·Granted Jan 28, 2014·0 cites·11 claims
- 3536US2017056561A1Compositions for the treatment of jointsCORMEDIX INC·Filed 2016·Application pending·0 cites
- 3635US2004033253A1Acyl opioid antagonistsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce Reidenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →